INDAPTA THERAPEUTICS INC has a total of 11 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets biotechnology and pharmaceuticals are KSQ THERAPEUTICS INC, ETAT FRANCAIS MINISTERE DE LA DEFENSE SERVICE DE SANTE DES ARMEES and GENITOPE CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | China | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Dipierro Guy | 11 |
#2 | Dos Santos Gary | 4 |
#3 | Bigley Austin | 1 |
#4 | Martell Ronald | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020107002A2 | Methods for expansion of natural killer (nk) cell subset and related compositions and methods | |
WO2019222293A1 | Subsets of human natural killer cells with enhanced antibody-directed immune responses | |
AU2018219895A1 | Engineered Natural Killer (NK) cells and compositions and methods thereof |